Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: Anixa Biosciences Inc (NASDAQ:ANIX), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Inovio Pharmaceuticals Inc (NASDAQ:INO), Elicio Therapeutics Inc (NASDAQ:ELTX) and Fate Therapeutics Inc (NASDAQ:FATE).
vTv Therapeutics has a consensus price target of $29.25.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $30.15 last updated November 18, 2025 at 4:09 PM EST.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.